WallStreetZenWallStreetZen

NASDAQ: KYTX
Kyverna Therapeutics Inc Stock Ownership - Who owns Kyverna Therapeutics?

Insider buying vs selling

Have Kyverna Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Bain Capital Life Sciences Investors LLC10% Owner2024-02-12450,000$22.00
$9.90MBuy
Gilead Sciences Inc10% Owner2024-02-12910,000$22.00
$20.02MBuy
Northpond Ventures Iii GP LLCInsider2024-02-12450,000$22.00
$9.90MBuy
Vida Ventures LLC10% Owner2024-02-12583$22.00
$12.83kBuy
Vida Ventures LLC10% Owner2024-02-12252,553$22.00
$5.56MBuy

1 of 1

KYTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KYTX insiders and whales buy or sell their stock.

KYTX Shareholders

What type of owners hold Kyverna Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vida Ventures LLC11.08%4,777,060$73.90MInsider
Fred E. Cohen10.49%4,523,924$69.99MInsider
Gilead Sciences Inc9.57%4,126,119$63.83MInsider
Northpond Ventures Iii GP LLC7.55%3,255,426$50.36MInsider
Bain Capital Life Sciences Investors LLC7.34%3,163,868$48.95MInsider
Beth C. Seidenberg1.71%735,984$11.39MInsider
Westlake Biopartners Fund I LP1.71%735,984$11.39MInsider
Dominique Christian Borie1.04%449,210$6.95MInsider
Peter Maag0.95%407,541$6.30MInsider
James Bum Chung0.15%65,918$1.02MInsider

1 of 2

KYTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KYTX0.00%51.65%Net BuyingNet Buying
NUVB50.10%49.90%Net Buying
DNTH24.91%75.09%Net Buying
SVRA32.26%67.74%Net BuyingNet Selling
HLVX65.85%34.15%Net SellingNet Selling

Kyverna Therapeutics Stock Ownership FAQ

Who owns Kyverna Therapeutics?

Kyverna Therapeutics (NASDAQ: KYTX) is owned by 0.00% institutional shareholders, 51.65% Kyverna Therapeutics insiders, and 48.35% retail investors. Vida Ventures LLC is the largest individual Kyverna Therapeutics shareholder, owning 4.78M shares representing 11.08% of the company. Vida Ventures LLC's Kyverna Therapeutics shares are currently valued at $71.70M.

If you're new to stock investing, here's how to buy Kyverna Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.